PMDA drug package insert
アセレンド注100μg
PMDA Prescription drug · 藤本製薬株式会社 · package insert Oct 16, 2024
Key facts
| Brand names | アセレンド注100μg |
|---|---|
| Nonproprietary names | 亜セレン酸ナトリウム |
| Companies | 製造販売元／藤本製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 低セレン血症治療剤 |
| Therapeutic category codes | 873229 |
| YJ codes | 3229402A1023 |
| Approval numbers | 23100AMX00291000 |
| Package insert edition | 第2版 |
| Package insert date | Oct 16, 2024 |
| PMDA document key | 670142_3229402A1023_1 |
| PMDA company code | 670142 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: